Therapeutic Areas

Pipeline

  • Treat the pain and inflammation locally, improving gout patient outcomes

  • Alleviate patient suffering from acute pain while mitigating the risks associated with current therapies

  • Restore vasodilation and increase circulation to affected areas

  • Target joints locally to deliver effective inflammation therapeutics safely for patients with chronic inflammation

  • Target the site of action of muscle spasms by delivering muscle relaxants locally

In Vitro

In Vivo

POC

Phase I

Phase 2